On October 28, 2025 BostonGene, developer of the leading AI foundation model for cancer and the immune system, reported the Company will present four posters at the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper)’s (SITC) (Free SITC Whitepaper) 40th Anniversary Annual Meeting, taking place November 5-9, 2025 in National Harbor, Maryland. BostonGene will also exhibit at booth 319.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BostonGene will highlight research demonstrating the power of its omnimodal foundation AI to advance precision oncology. The studies showcase innovative approaches for identifying predictive biomarkers, optimizing patient selection in clinical trials, forecasting treatment-related toxicities through blood-based profiling and assessing the impact of combination therapies in B-cell non-Hodgkin lymphoma.
Scientific poster presentations details are below:
Friday, November 7
Abstract: 153
Title: Association of candidate tertiary lymphoid structures in baseline tumor tissue with response to ipilimumab in patients with metastatic castration-resistant prostate cancer (mCRPC)
Saturday, November 8
Abstract: 154
Title: Machine-learning tool Helenus enhances gene expression profiling to improve biomarker discovery in lung adenocarcinoma cohorts and advance the precision of immunotherapy
Abstract: 504
Title: Biological Mechanisms of Resistance to Macrophage Checkpoint Inhibitors in Relapsed B-cell Non-Hodgkin Lymphoma
Abstract: 1094
Title: Pre-treatment predictive modeling of immune-related adverse event risk in immune checkpoint blockade therapy: A multi-modal machine learning approach from a real-world setting (RADIOHEAD Cohort Study)
Abstracts will be published on November 4 in the Journal for ImmunoTherapy of Cancer (JITC), SITC (Free SITC Whitepaper)’s official journal. To learn more or to schedule a meeting with BostonGene during SITC (Free SITC Whitepaper), please contact Hannah Oman at [email protected].
(Press release, BostonGene, OCT 28, 2025, View Source [SID1234657084])